New Drugs for Diabetes and Cancer Patients Thanks to Sanofi
It was good news this week for Sanofi, as the French pharma company received separate European approvals for drugs to treat diabetes and cancer. The drug Lyxumia was granted marketing authorisation for use in adults with type 2 diabetes to…